Lv4
496 积分 2026-02-24 加入
TAS0612, a Novel RSK, AKT, and S6K Inhibitor, Exhibits Antitumor Effects in Preclinical Tumor Models
2个月前
已完结
Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses
2个月前
已完结
RiSKs in Computational Modeling of Isoform-Selective RSK Inhibitors
2个月前
已完结
Discovery of 2-Amino-7-Amide Quinazoline Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Extracellular Signal-Regulated Kinase 1/2
3个月前
已完结
Design and Structural Optimization of Orally Bioavailable RSK4 Inhibitors for the Treatment of Esophageal Squamous Cell Carcinoma
3个月前
已完结
皖公网安备34019202002308
